Cargando…
Multimodal Molecular Imaging Reveals Tissue-Based T Cell Activation and Viral RNA Persistence for Up to 2 Years Following COVID-19
The etiologic mechanisms of post-acute medical morbidities and unexplained symptoms (Long COVID) following SARS-CoV-2 infection are incompletely understood. There is growing evidence that viral persistence and immune dysregulation may play a major role. We performed whole-body positron emission tomo...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418298/ https://www.ncbi.nlm.nih.gov/pubmed/37577714 http://dx.doi.org/10.1101/2023.07.27.23293177 |
_version_ | 1785088229573132288 |
---|---|
author | Peluso, Michael J. Ryder, Dylan Flavell, Robert Wang, Yingbing Levi, Jelena LaFranchi, Brian H. Deveau, Tyler-Marie Buck, Amanda M. Munter, Sadie E. Asare, Kofi A. Aslam, Maya Koch, Wally Szabo, Gyula Hoh, Rebecca Deswal, Monika Rodriguez, Antonio Buitrago, Melissa Tai, Viva Shrestha, Uttam Lu, Scott Goldberg, Sarah A. Dalhuisen, Thomas Durstenfeld, Matthew S. Hsue, Priscilla Y. Kelly, J. Daniel Kumar, Nitasha Martin, Jeffrey N. Gambir, Aruna Somsouk, Ma Seo, Youngho Deeks, Steven G. Laszik, Zoltan G. VanBrocklin, Henry F. Henrich, Timothy J. |
author_facet | Peluso, Michael J. Ryder, Dylan Flavell, Robert Wang, Yingbing Levi, Jelena LaFranchi, Brian H. Deveau, Tyler-Marie Buck, Amanda M. Munter, Sadie E. Asare, Kofi A. Aslam, Maya Koch, Wally Szabo, Gyula Hoh, Rebecca Deswal, Monika Rodriguez, Antonio Buitrago, Melissa Tai, Viva Shrestha, Uttam Lu, Scott Goldberg, Sarah A. Dalhuisen, Thomas Durstenfeld, Matthew S. Hsue, Priscilla Y. Kelly, J. Daniel Kumar, Nitasha Martin, Jeffrey N. Gambir, Aruna Somsouk, Ma Seo, Youngho Deeks, Steven G. Laszik, Zoltan G. VanBrocklin, Henry F. Henrich, Timothy J. |
author_sort | Peluso, Michael J. |
collection | PubMed |
description | The etiologic mechanisms of post-acute medical morbidities and unexplained symptoms (Long COVID) following SARS-CoV-2 infection are incompletely understood. There is growing evidence that viral persistence and immune dysregulation may play a major role. We performed whole-body positron emission tomography (PET) imaging in a cohort of 24 participants at time points ranging from 27 to 910 days following acute SARS-CoV-2 infection using a novel radiopharmaceutical agent, [(18)F]F-AraG, a highly selective tracer that allows for anatomical quantitation of activated T lymphocytes. Tracer uptake in the post-acute COVID group, which included those with and without Long COVID symptoms, was significantly higher compared to pre-pandemic controls in many anatomical regions, including the brain stem, spinal cord, bone marrow, nasopharyngeal and hilar lymphoid tissue, cardiopulmonary tissues, and gut wall. Although T cell activation tended to be higher in participants imaged closer to the time of the acute illness, tracer uptake was increased in participants imaged up to 2.5 years following SARS-CoV-2 infection. We observed that T cell activation in spinal cord and gut wall was associated with the presence of Long COVID symptoms. In addition, tracer uptake in lung tissue was higher in those with persistent pulmonary symptoms. Notably, increased T cell activation in these tissues was also observed in many individuals without Long COVID. Given the high [(18)F]F-AraG uptake detected in the gut, we obtained colorectal tissue for in situ hybridization SARS-CoV-2 RNA and immunohistochemical studies in a subset of participants with Long COVID symptoms. We identified cellular SARS-CoV-2 RNA in rectosigmoid lamina propria tissue in all these participants, ranging from 158 to 676 days following initial COVID-19 illness, suggesting that tissue viral persistence could be associated with long-term immunological perturbations. |
format | Online Article Text |
id | pubmed-10418298 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cold Spring Harbor Laboratory |
record_format | MEDLINE/PubMed |
spelling | pubmed-104182982023-08-12 Multimodal Molecular Imaging Reveals Tissue-Based T Cell Activation and Viral RNA Persistence for Up to 2 Years Following COVID-19 Peluso, Michael J. Ryder, Dylan Flavell, Robert Wang, Yingbing Levi, Jelena LaFranchi, Brian H. Deveau, Tyler-Marie Buck, Amanda M. Munter, Sadie E. Asare, Kofi A. Aslam, Maya Koch, Wally Szabo, Gyula Hoh, Rebecca Deswal, Monika Rodriguez, Antonio Buitrago, Melissa Tai, Viva Shrestha, Uttam Lu, Scott Goldberg, Sarah A. Dalhuisen, Thomas Durstenfeld, Matthew S. Hsue, Priscilla Y. Kelly, J. Daniel Kumar, Nitasha Martin, Jeffrey N. Gambir, Aruna Somsouk, Ma Seo, Youngho Deeks, Steven G. Laszik, Zoltan G. VanBrocklin, Henry F. Henrich, Timothy J. medRxiv Article The etiologic mechanisms of post-acute medical morbidities and unexplained symptoms (Long COVID) following SARS-CoV-2 infection are incompletely understood. There is growing evidence that viral persistence and immune dysregulation may play a major role. We performed whole-body positron emission tomography (PET) imaging in a cohort of 24 participants at time points ranging from 27 to 910 days following acute SARS-CoV-2 infection using a novel radiopharmaceutical agent, [(18)F]F-AraG, a highly selective tracer that allows for anatomical quantitation of activated T lymphocytes. Tracer uptake in the post-acute COVID group, which included those with and without Long COVID symptoms, was significantly higher compared to pre-pandemic controls in many anatomical regions, including the brain stem, spinal cord, bone marrow, nasopharyngeal and hilar lymphoid tissue, cardiopulmonary tissues, and gut wall. Although T cell activation tended to be higher in participants imaged closer to the time of the acute illness, tracer uptake was increased in participants imaged up to 2.5 years following SARS-CoV-2 infection. We observed that T cell activation in spinal cord and gut wall was associated with the presence of Long COVID symptoms. In addition, tracer uptake in lung tissue was higher in those with persistent pulmonary symptoms. Notably, increased T cell activation in these tissues was also observed in many individuals without Long COVID. Given the high [(18)F]F-AraG uptake detected in the gut, we obtained colorectal tissue for in situ hybridization SARS-CoV-2 RNA and immunohistochemical studies in a subset of participants with Long COVID symptoms. We identified cellular SARS-CoV-2 RNA in rectosigmoid lamina propria tissue in all these participants, ranging from 158 to 676 days following initial COVID-19 illness, suggesting that tissue viral persistence could be associated with long-term immunological perturbations. Cold Spring Harbor Laboratory 2023-07-31 /pmc/articles/PMC10418298/ /pubmed/37577714 http://dx.doi.org/10.1101/2023.07.27.23293177 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. |
spellingShingle | Article Peluso, Michael J. Ryder, Dylan Flavell, Robert Wang, Yingbing Levi, Jelena LaFranchi, Brian H. Deveau, Tyler-Marie Buck, Amanda M. Munter, Sadie E. Asare, Kofi A. Aslam, Maya Koch, Wally Szabo, Gyula Hoh, Rebecca Deswal, Monika Rodriguez, Antonio Buitrago, Melissa Tai, Viva Shrestha, Uttam Lu, Scott Goldberg, Sarah A. Dalhuisen, Thomas Durstenfeld, Matthew S. Hsue, Priscilla Y. Kelly, J. Daniel Kumar, Nitasha Martin, Jeffrey N. Gambir, Aruna Somsouk, Ma Seo, Youngho Deeks, Steven G. Laszik, Zoltan G. VanBrocklin, Henry F. Henrich, Timothy J. Multimodal Molecular Imaging Reveals Tissue-Based T Cell Activation and Viral RNA Persistence for Up to 2 Years Following COVID-19 |
title | Multimodal Molecular Imaging Reveals Tissue-Based T Cell Activation and Viral RNA Persistence for Up to 2 Years Following COVID-19 |
title_full | Multimodal Molecular Imaging Reveals Tissue-Based T Cell Activation and Viral RNA Persistence for Up to 2 Years Following COVID-19 |
title_fullStr | Multimodal Molecular Imaging Reveals Tissue-Based T Cell Activation and Viral RNA Persistence for Up to 2 Years Following COVID-19 |
title_full_unstemmed | Multimodal Molecular Imaging Reveals Tissue-Based T Cell Activation and Viral RNA Persistence for Up to 2 Years Following COVID-19 |
title_short | Multimodal Molecular Imaging Reveals Tissue-Based T Cell Activation and Viral RNA Persistence for Up to 2 Years Following COVID-19 |
title_sort | multimodal molecular imaging reveals tissue-based t cell activation and viral rna persistence for up to 2 years following covid-19 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418298/ https://www.ncbi.nlm.nih.gov/pubmed/37577714 http://dx.doi.org/10.1101/2023.07.27.23293177 |
work_keys_str_mv | AT pelusomichaelj multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19 AT ryderdylan multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19 AT flavellrobert multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19 AT wangyingbing multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19 AT levijelena multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19 AT lafranchibrianh multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19 AT deveautylermarie multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19 AT buckamandam multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19 AT muntersadiee multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19 AT asarekofia multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19 AT aslammaya multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19 AT kochwally multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19 AT szabogyula multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19 AT hohrebecca multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19 AT deswalmonika multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19 AT rodriguezantonio multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19 AT buitragomelissa multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19 AT taiviva multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19 AT shresthauttam multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19 AT luscott multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19 AT goldbergsaraha multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19 AT dalhuisenthomas multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19 AT durstenfeldmatthews multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19 AT hsuepriscillay multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19 AT kellyjdaniel multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19 AT kumarnitasha multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19 AT martinjeffreyn multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19 AT gambiraruna multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19 AT somsoukma multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19 AT seoyoungho multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19 AT deekssteveng multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19 AT laszikzoltang multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19 AT vanbrocklinhenryf multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19 AT henrichtimothyj multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19 |